PROVIDENCE, R.I.--(BUSINESS WIRE)--Afferent Corporation, an early-stage medical device company focused on treating neurologic dysfunction, announced today an investment by Stryker Corporation (NYSE: SYK). As part of the transaction, Stryker will have access to certain aspects of Afferent’s technology.
